Literature DB >> 17595346

Fuel economy in food-deprived skeletal muscle: signaling pathways and regulatory mechanisms.

Pieter de Lange1, Maria Moreno, Elena Silvestri, Assunta Lombardi, Fernando Goglia, Antonia Lanni.   

Abstract

Energy deprivation poses a tremendous challenge to skeletal muscle. Glucose (ATP) depletion causes muscle fibers to undergo rapid adaptive changes toward the use of fatty acids (instead of glucose) as fuel. Physiological situations involving energy deprivation in skeletal muscle include exercise and fasting. A vast body of evidence is available on the signaling pathways that lead to structural/metabolic changes in muscle during exercise and endurance training. In contrast, only recently has a systematic, overall picture been obtained of the signaling processes (and their kinetics and sequential order) that lead to adaptations of the muscle to the fasting state. It has become clear that the reaction of the organism to food restraint or deprivation involves a rapid signaling process causing skeletal muscles, which generally use glucose as their predominant fuel, to switch to the use of fat as fuel. Efficient sensing of glucose depletion in skeletal muscle guarantees maintained activity in those tissues that rely entirely on glucose (such as the brain). To metabolize fatty acids, skeletal muscle needs to activate complex transcription, translation, and phosphorylation pathways. Only recently has it become clear that these pathways are interrelated and tightly regulated in a rapid, transient manner. Food deprivation may trigger these responses with a timing/intensity that differs among animal species and that may depend on their individual ability to induce structural/metabolic changes that serve to safeguard whole-body energy homeostasis in the longer term. The increased cellular AMP/ATP ratio induced by food deprivation, which results in activation of AMP-activated protein kinase (AMPK), initiates a rapid signaling process, resulting in the recruitment of factors mediating the structural/metabolic shift in skeletal muscle toward this change in fuel usage. These factors include peroxisome proliferator-activated receptor (PPAR)gamma coactivator-1alpha (PGC-1alpha), PPARdelta, and their target genes, which are involved in the formation of oxidative muscle fibers, mitochondrial biogenesis, oxidative phosphorylation, and fatty acid oxidation. Fatty acids, besides being the fuel for mitochondrial oxidation, have been identified as important signaling molecules regulating the transcription and/or activity of the genes or gene products involved in fatty acid metabolism during food deprivation. It is thus becoming increasingly clear that fatty acids determine the economy of their own usage. We discuss the order of events from the onset of food deprivation and their importance.

Entities:  

Mesh:

Year:  2007        PMID: 17595346     DOI: 10.1096/fj.07-8527rev

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  51 in total

1.  Bile acid receptor agonist GW4064 regulates PPARγ coactivator-1α expression through estrogen receptor-related receptor α.

Authors:  Shailendra Kumar Dhar Dwivedi; Nidhi Singh; Rashmi Kumari; Jay Sharan Mishra; Sarita Tripathi; Priyam Banerjee; Priyanka Shah; Vandana Kukshal; Abdul Malik Tyagi; Anil Nilkanth Gaikwad; Rajnish Kumar Chaturvedi; Durga Prasad Mishra; Arun Kumar Trivedi; Somali Sanyal; Naibedya Chattopadhyay; Ravishankar Ramachandran; Mohammad Imran Siddiqi; Arun Bandyopadhyay; Ashish Arora; Thomas Lundåsen; Sayee Priyadarshini Anakk; David D Moore; Sabyasachi Sanyal
Journal:  Mol Endocrinol       Date:  2011-04-14

2.  CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress.

Authors:  Zaher Nahlé; Michael Hsieh; Terri Pietka; Chris T Coburn; Paul A Grimaldi; Michael Q Zhang; Debopriya Das; Nada A Abumrad
Journal:  J Biol Chem       Date:  2008-02-28       Impact factor: 5.157

Review 3.  FoxO1, the transcriptional chief of staff of energy metabolism.

Authors:  Stavroula Kousteni
Journal:  Bone       Date:  2011-07-28       Impact factor: 4.398

4.  Protective Effects of Ghrelin on Fasting-Induced Muscle Atrophy in Aging Mice.

Authors:  Chia-Shan Wu; Qiong Wei; Hongying Wang; Da Mi Kim; Miriam Balderas; Guoyao Wu; John Lawler; Stephen Safe; Shaodong Guo; Sridevi Devaraj; Zheng Chen; Yuxiang Sun
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-03-09       Impact factor: 6.053

5.  Sequential changes in the expression of genes involved in lipid metabolism in adipose tissue and liver in response to fasting.

Authors:  M Palou; T Priego; J Sánchez; E Villegas; A M Rodríguez; A Palou; C Picó
Journal:  Pflugers Arch       Date:  2008-05-21       Impact factor: 3.657

Review 6.  Histone Deacetylases and Cardiometabolic Diseases.

Authors:  Kan Hui Yiew; Tapan K Chatterjee; David Y Hui; Neal L Weintraub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-07-16       Impact factor: 8.311

Review 7.  Thyroid hormone analogues and derivatives: Actions in fatty liver.

Authors:  Maria Coppola; Daniela Glinni; Maria Moreno; Federica Cioffi; Elena Silvestri; Fernando Goglia
Journal:  World J Hepatol       Date:  2014-03-27

8.  Uncoupling protein 3 expression levels influence insulin sensitivity, fatty acid oxidation, and related signaling pathways.

Authors:  Rosalba Senese; Vivien Valli; Maria Moreno; Assunta Lombardi; Rosa Anna Busiello; Federica Cioffi; Elena Silvestri; Fernando Goglia; Antonia Lanni; Pieter de Lange
Journal:  Pflugers Arch       Date:  2010-11-07       Impact factor: 3.657

9.  AMP-activated protein kinase (AMPK)α2 plays a role in determining the cellular fate of glucose in insulin-resistant mouse skeletal muscle.

Authors:  R S Lee-Young; J S Bonner; W H Mayes; I Iwueke; B A Barrick; C M Hasenour; L Kang; D H Wasserman
Journal:  Diabetologia       Date:  2012-12-08       Impact factor: 10.122

10.  Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis.

Authors:  Miguel García; Anna Pujol; Albert Ruzo; Efrén Riu; Jesús Ruberte; Anna Arbós; Anna Serafín; Beatriz Albella; Juan Emilio Felíu; Fátima Bosch
Journal:  PLoS Genet       Date:  2009-08-21       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.